Common putative risk genes for RCC and melanoma – BAP1, MITF, CDKN2B – suggest that similar pathways are disrupted in both disorders; however, individual variant risks should be evaluated when shared genetic background is taken into account. This evidence concerns the gene BAP1 and renal cell carcinoma.